Elias Gebru

504 citations
19 papers · 409 indexed · h-index 12
Topics
Antibiotics Pharmacokinetics and Efficacy (8 papers)Antibiotic Resistance in Bacteria (7 papers)Microbial infections and disease research (4 papers)

In The Last Decade

Elias Gebru

19 papers receiving 397 citations

Peers

Elias Gebru
Comparison fields: 5 of 81
  • Pharmacology 129
  • Microbiology 92
  • Molecular Biology 87
  • Molecular Medicine 80
  • Food Science 67
Replace Dereje Damte with:
Dereje Damte South Korea
Ákos Jerzsele Hungary
Chandra Datta Sumi Australia
JeongWoo Kang South Korea
Nikolina Rusenova Bulgaria
Zuoting Yan China
G Semjén Hungary
G. Albarellos Argentina
S. Carli Italy
H. VAN GOGH Netherlands
Elias Gebru relative to Dereje Damte South Korea Dereje Damte's profile →
Citations per field
00.5×1.5×
Dereje Damte · 1×
Citations per year

Countries citing papers authored by Elias Gebru

Since Specialization
Citations

This map shows the geographic impact of Elias Gebru's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elias Gebru with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elias Gebru more than expected).

Fields of papers citing papers by Elias Gebru

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elias Gebru. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elias Gebru. The network helps show where Elias Gebru may publish in the future.

Co-authorship network of co-authors of Elias Gebru

This figure shows the co-authorship network connecting the top 25 collaborators of Elias Gebru. A scholar is included among the top collaborators of Elias Gebru based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elias Gebru. Elias Gebru is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 2
2 2
3 15
4
The in vitro antibacterial activity of florfenicol in combination with amoxicillin or cefuroxime against pathogenic bacteria of animal origin.
10
5 25
6 15
7 39
8 58
9 6
10 4
11 30
12 4
13 86
14 13
15 30
16 25
17 17
18 6
19 22

About Elias Gebru

Elias Gebru is a scholar working on Molecular Medicine, Microbiology and Pharmacology, having authored 19 papers that have together received 409 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (7 papers) and Microbial infections and disease research (4 papers). The work is most often cited by research in Molecular Medicine (80 citations), Microbiology (92 citations) and Pharmacology (129 citations). Elias Gebru has collaborated with scholars based in South Korea, United States and China. Frequent co-authors include Seung‐Chun Park, Henrique Cheng, Zhiqiang Chang, Dereje Damte, Joong‐Su Lee, Myeongjin Choi, Seung‐Jin Lee, Man Hee Rhee, Jong-Choon Kim and Min‐Kyu Kim. Their work appears in journals such as SHILAP Revista de lepidopterología, Biochemical and Biophysical Research Communications and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026